Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement.
Cell Discov
; 6: 61, 2020.
Article
in English
| MEDLINE | ID: covidwho-752513
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Randomized controlled trials
Language:
English
Journal:
Cell Discov
Year:
2020
Document Type:
Article
Affiliation country:
S41421-020-00199-1
Similar
MEDLINE
...
LILACS
LIS